D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Emerson Electric
EMR
|
+$577M |
| 2 |
Amazon
AMZN
|
+$538M |
| 3 |
Tesla
TSLA
|
+$501M |
| 4 |
Netflix
NFLX
|
+$352M |
| 5 |
Adobe
ADBE
|
+$342M |
Top Sells
| 1 |
Alibaba
BABA
|
+$945M |
| 2 |
NVIDIA
NVDA
|
+$485M |
| 3 |
CELG
Celgene Corp
CELG
|
+$460M |
| 4 |
ConocoPhillips
COP
|
+$344M |
| 5 |
Biogen
BIIB
|
+$322M |
Sector Composition
| 1 | Technology | 20.59% |
| 2 | Consumer Discretionary | 15.86% |
| 3 | Healthcare | 13.39% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Cross Country Healthcare
CCRN
$460M
| $203K | ﹤0.01% |
17,500
-10,785
| -38% | -$125K |
|
2452
Sterling Infrastructure
STRL
$9.08B
| $201K | ﹤0.01% |
14,269
-9,385
| -40% | -$132K |
|
|
ORTX
2453
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $200K | ﹤0.01% |
+1,458
| New | +$200K |
|
|
ACGN
2454
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $200K | ﹤0.01% |
6,479
-308
| -5% | -$9.51K |
|
2455
TFS Financial
TFSL
$3.73B
| $199K | ﹤0.01% |
10,126
-6,677
| -40% | -$131K |
|
2456
American Coastal Insurance
ACIC
$534M
| $198K | ﹤0.01% |
+15,678
| New | +$198K |
|
|
CMO
2457
DELISTED
Capstead Mortgage Corp.
CMO
| $198K | ﹤0.01% |
+25,029
| New | +$198K |
|
|
DS
2458
DELISTED
Drive Shack Inc.
DS
| $196K | ﹤0.01% |
53,490
+6,721
| +14% | +$24.6K |
|
2459
Cytosorbents Corp
CTSO
$62.1M
| $195K | ﹤0.01% |
+50,767
| New | +$195K |
|
|
SFE
2460
DELISTED
Safeguard Scientifics, Inc.
SFE
| $195K | ﹤0.01% |
17,776
-25,859
| -59% | -$284K |
|
2461
HBT Financial
HBT
$812M
| $194K | ﹤0.01% |
+10,237
| New | +$194K |
|
2462
DigitalBridge
DBRG
$2.06B
| $193K | ﹤0.01% |
10,163
-1,967
| -16% | -$37.4K |
|
|
CNSL
2463
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $193K | ﹤0.01% |
49,690
+27,486
| +124% | +$107K |
|
2464
Barnes & Noble Education
BNED
$287M
| $191K | ﹤0.01% |
448
-149
| -25% | -$63.5K |
|
2465
Newmark Group
NMRK
$3.35B
| $190K | ﹤0.01% |
14,145
-4,280
| -23% | -$57.5K |
|
2466
Gladstone Investment Corp
GAIN
$545M
| $189K | ﹤0.01% |
+14,282
| New | +$189K |
|
|
ITI
2467
DELISTED
Iteris, Inc.
ITI
| $187K | ﹤0.01% |
37,555
-14,759
| -28% | -$73.5K |
|
2468
Rafael Holdings
RFL
$52.7M
| $186K | ﹤0.01% |
10,599
-4,222
| -28% | -$74.1K |
|
2469
Anavex Life Sciences
AVXL
$851M
| $185K | ﹤0.01% |
+71,550
| New | +$185K |
|
2470
Hecla Mining
HL
$7.19B
| $185K | ﹤0.01% |
54,500
+32,956
| +153% | +$112K |
|
2471
Intellia Therapeutics
NTLA
$1.27B
| $185K | ﹤0.01% |
+12,625
| New | +$185K |
|
2472
Duluth Holdings
DLTH
$128M
| $184K | ﹤0.01% |
+17,502
| New | +$184K |
|
2473
Wave Life Sciences
WVE
$1.22B
| $181K | ﹤0.01% |
22,548
+3,858
| +21% | +$31K |
|
2474
Fidus Investment
FDUS
$757M
| $180K | ﹤0.01% |
+12,112
| New | +$180K |
|
|
AXAS
2475
DELISTED
Abraxas Petroleum Corporation
AXAS
| $180K | ﹤0.01% |
25,579
-15,677
| -38% | -$110K |
|